Short answer
Trevi Therapeutics, Inc. (TRVI) filed an 8-K current report with the SEC on June 4, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 5.07 (Submission of Matters to a Vote of Security Holders). Shareholders approved 8,000,000 additional common shares for the A&R 2019 Stock Incentive Plan.
Trevi Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Shareholders approved 8,000,000 additional common shares for the A&R 2019 Stock Incentive Plan
- Expanded equity pool supports employee and director retention but increases potential shareholder dilution
- Non-employee director compensation limits add governance controls on equity awards
- Prohibited share recycling and forfeitable dividends tighten plan administration and reduce future grant capacity
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Authorized common shares doubled from 200,000,000 to 400,000,000
- Stockholder-approved amendment effective June 3, 2026, following Delaware filing
- Expanded share capacity enables potential equity raises, acquisitions, or employee compensation
- Potential dilution risk for existing shareholders if newly authorized shares are issued
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Michael Heffernan elected Class I director through 2029, strengthening board continuity
- Ernst & Young reappointed for fiscal 2026, with 114,001,970 votes supporting auditor ratification
- Executive compensation approved advisory, with 98,119,461 votes in favor
- A&R 2019 Plan approved, supporting continued equity-based compensation capacity
- Authorized common shares doubled from 200,000,000 to 400,000,000, expanding potential financing and dilution capacity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Trevi Therapeutics, Inc. 8-K filings
Get the next TRVI 8-K as it lands
Follow TRVI for push alerts, or ask the research agent what this filing means.